Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Alimera Sciences Inc (ALIM)  
$0.31 0.00 (0.00%) as of 4:30 Fri 2/14


Download
   
Exchange: Nasdaq Small Cap
Security Type: Common
Shares Out: 52,420,000
Market Cap: 15.99(M)
Last Volume: 24,690 Avg Vol: 24,621
52 Week Range: $0.305 - $0.305
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Major

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Alimera Sciences is a pharmaceutical company that focuses on the commercialization and development of ophthalmic pharmaceuticals. Co. focuses on diseases affecting the retina. Co.'s commercial product is ILUVIEN®, an intravitreal implant that treats patients by delivering a continuous microdose of the corticosteroid fluocinolone acetonide in the eye, for up to 36 months. ILUVIEN is also used in certain countries in the European Economic Area to prevent relapse in recurrent non-infectious uveitis affecting the posterior segment of the eye. LUVIEN is inserted into the back of the patient's eye in a non-surgical procedure employing a device with a needle, which allows for a self-sealing wound.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 1,980,901 1,980,901
Total Buy Value $0 $0 $4,346,042 $4,346,042
Total People Bought 0 0 2 2
Total Buy Transactions 0 0 2 2
Total Shares Sold 0 0 579,000 779,919
Total Sell Value $0 $0 $1,962,810 $2,276,927
Total People Sold 0 0 1 2
Total Sell Transactions 0 0 1 2
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 322
  Page 5 of 13  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Holland David Chief Marketing Officer & SVP   •       –      –    2019-11-15 4 A $4.75 $808 D/D 170 17,795     -
   Jones John Philip Chief Financial Officer   •       –      –    2019-11-15 4 A $4.75 $594 D/D 125 8,431     -
   Eiswirth Richard S Jr President and CEO   •       •      –    2019-11-14 4/A B $0.30 $29,890 D/D 100,000 463,901 2.81     -
   Eiswirth Richard S Jr President and CEO   •       •      –    2019-11-14 4 A $0.30 $29,890 D/D 100,000 463,901     -
   Jones John Philip Chief Financial Officer   •       –      –    2019-11-01 4/A B $0.30 $3,008 D/D 10,000 124,590 2.66     -
   Jones John Philip Chief Financial Officer   •       –      –    2019-11-01 4 A $0.30 $3,008 D/D 10,000 124,590     -
   Eiswirth Richard S Jr President and CEO   •       •      –    2019-10-31 4 A $0.24 $2,138 D/D 7,919 363,901     -
   Jones John Philip Chief Financial Officer   •       –      –    2019-10-31 4 A $0.24 $1,199 D/D 4,604 114,590     -
   Holland David Chief Marketing Officer & SVP   •       –      –    2019-10-31 4 A $0.24 $1,410 D/D 5,350 264,379     -
   Kaba Samer Chief Medical Officer   •       –      –    2019-10-31 4 A $0.28 $712 D/D 2,513 78,277     -
   Eiswirth Richard S Jr President and CEO   •       •      –    2019-10-15 4 A $0.40 $1,536 D/D 3,839 355,982     -
   Jones John Philip Chief Financial Officer   •       –      –    2019-10-15 4 A $0.40 $596 D/D 1,490 109,986     -
   Kaba Samer Chief Medical Officer   •       –      –    2019-10-15 4 A $0.40 $712 D/D 1,779 75,764     -
   Holland David Chief Marketing Officer & SVP   •       –      –    2019-10-15 4 A $0.40 $808 D/D 2,020 259,029     -
   Kaba Samer Chief Medical Officer   •       –      –    2019-09-30 4 A $0.57 $712 D/D 1,249 73,985     -
   Holland David Chief Marketing Officer & SVP   •       –      –    2019-09-30 4 A $0.57 $808 D/D 1,417 257,009     -
   Jones John Philip Chief Financial Officer   •       –      –    2019-09-30 4 A $0.57 $596 D/D 1,046 108,496     -
   Eiswirth Richard S Jr President and CEO   •       •      –    2019-09-30 4 A $0.57 $1,536 D/D 2,694 352,143     -
   Holland David Chief Marketing Officer & SVP   •       –      –    2019-09-13 4 A $0.41 $808 D/D 1,970 255,592     -
   Kaba Samer Chief Medical Officer   •       –      –    2019-09-13 4 A $0.41 $712 D/D 1,736 72,736     -
   Jones John Philip Chief Financial Officer   •       –      –    2019-09-13 4 A $0.41 $596 D/D 1,454 107,450     -
   Eiswirth Richard S Jr President and CEO   •       •      –    2019-09-13 4 A $0.41 $1,535 D/D 3,745 349,449     -
   Jones John Philip Chief Financial Officer   •       –      –    2019-04-30 4 A $0.82 $1,346 D/D 1,633 110,229     -
   Eiswirth Richard S Jr President and CEO   •       –      –    2019-04-30 4 A $0.82 $2,061 D/D 2,500 345,704     -
   Kaba Samer Chief Medical OfficerOfficer   •       –      –    2019-04-04 3 IO $0.00 $0 D/D 0 71,000     -
  322 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 5 of 13
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us